Company Summary

Opsona Therapeutics Limited was set up on Tuesday the 9th of March 2004. Their current partial address is Dublin 2, and the company status is Dissolved with the company closing on Tuesday the 20th of July 2021. The company has 8 directors who have also been the directors of 19 other Irish companies between them; 2 of which are now closed. Opsona Therapeutics Limited has 26 shareholders. This Irish company shares its Eircode with at least 814 other companies.

Company Name:Opsona Therapeutics Limited
Company Status:DISSOLVED
NOTICE TO PREFERENTIAL CREDITORS - PROOF OF DEBTS/CLAIMS REQUIRED
NOTICE TO CREDITORS - PROOF OF DEBTS/CLAIMS REQUIRED
Took place on 23/09/2019
NOTICE TO PREFERENTIAL CREDITORS - PROOF OF DEBTS/CLAIMS REQUIRED
MEETING OF CREDITORS
Took place on 24/01/2019
Company Address:1 Stokes Place,
Saint Stephen's Green,
Dublin 2
Telephone:+353 (0)1 677 0223
Key Executive:Mr O'Neill
Company Size:Log-In To View
Established:09/03/2004 (17 years in business).
Disclaimer Other Details
Please note the contact details displayed above are collected from a variety of public sources and are appended to this report for your convenience. As they are non-CRO data, we can not vouch for their accuracy or timeliness. To update contact details on this company simply email us.

Key Contact Profile

Mr O'Neill is a Company Director of Opsona Therapeutics Limited since 2007 and a listed Director of 3 other companies.

Generate a B2B Marketing List with ease and grow your business. Identify key decision makers and pre-qualified new prospects for your sales and business development teams.

Similar Companies - Create a marketing list of similar companies

Latest Updates

The latest documents filed with the Companies Registration Office for Opsona Therapeutics Limited (which can include the Account Details) are listed below.

CRO DocumentEffective DateReceived By CROView Now
Form E7 - Final Wind up Meeting - Members & Creditors22/03/202131/03/2021Join Up
Form E5: Liquidator`s Final Statement of Accounts22/03/202131/03/2021Join Up
Form G1 - Special Resolution to Wind up22/03/202131/03/2021Join Up
Form E4: Liquidator`s Statement of Proceedings and Position of Winding Up22/03/202131/03/2021Join Up
Form E3: Liquidator`s Accounts of Acts & Dealings23/01/202105/03/2021Join Up
THIS COMPANY HAS 180 OTHER DOCS »

View CRO company documents and company reports any Irish company or business with ease.

Credit Report

View the Latest Credit Report and Credit Limit on Opsona Therapeutics Limited.

Company Status:Dissolved
NOTICE TO PREFERENTIAL CREDITORS - PROOF OF DEBTS/CLAIMS REQUIRED
NOTICE TO CREDITORS - PROOF OF DEBTS/CLAIMS REQUIRED
Took place on 23/09/2019
NOTICE TO PREFERENTIAL CREDITORS - PROOF OF DEBTS/CLAIMS REQUIRED
MEETING OF CREDITORS
Took place on 24/01/2019
Latest Credit Movement:
Date of Last Movement:05/08/2025
Latest Accounts Filed:08/08/2018
Report Based on Accounts:31/12/2016
Next Set of Accounts Due:09/09/2018
Overdue:Yes
Credit Score:Join-Up to View

Full Credit Rating

To View the latest Credit Rating or Credit Limit on Opsona Therapeutics Limited simply click 'Log-In' or 'Join-Up' below.

Vision-net Credit Scores save your business the time and cost of chasing slow payers. Evaluate risk at client application stage or run continuous credit checks on your full customer base.

Directors & Owners

Satisfy due diligence requirements on Opsona Therapeutics Limited in one single 'time-saving' search. Run full background checks for Fitness and Probity on the directors of Opsona Therapeutics Limited and Anti-Money Laundering checks (AML checks) on Opsona Therapeutics Limited

Directors details are available to logged in users.

Ownership Structure

Company Type:LTD - Private Company Limited By Shares
Number of Shareholders:26

Compliance

Log-in now to run Due Diligence checks and Compliance checks on Opsona Therapeutics Limited or click Join-up to get started.

Background check Companies, Sole Traders or Individuals and minimise your spend with more efficient Anti-Money Laundering checks and reports.

Ask Us A Question...?

NACE Rev. 2.1: What the 2026 Update Means for Your Reporting

09/02/2026

From 1 January 2026, EU authorities require institutions to report counterparty economic activity using the updated NACE Rev.2.1 classification.

Read More »

Commercial Judgments Up 67% as Insolvencies Shift Toward Older Firms

03/02/2026

While 2025 data highlights sustained momentum in new company formation (26,500 start-ups), emerging indicators point to growing financial strain across the corporate sector.

Read More »

Ireland Records Strongest Year for Start-ups in 15 Years.

26/01/2026

According to our latest data, 2025 was the strongest year for Irish entrepreneurship, with 26,500 new companies formed

Read More »

It's Time to Kick Off 2026

16/01/2026

As we kick off 2026, we're thrilled to announce a series of enhancements coming your way over the next 12 months...

Read More »